CD47 and PD-L1 overexpression in proliferating human hepatocytes attenuated immune responses and ameliorated acute liver injury in mice
文献类型:期刊论文
作者 | Ma, Chen8,9; Cao, Huiying8,9; Sun, Zhen1,6,7; Deng, Qiangqiang8,9; Liu, Wenjing5,9; Xin, Yingying8,9; Qiao, Shida8,9; Cen, Jin1,7; Shu, Yajing1,7; Qi, Kai4 |
刊名 | AMERICAN JOURNAL OF TRANSPLANTATION |
出版日期 | 2023-12-01 |
卷号 | 23期号:12页码:1832-1844 |
ISSN号 | 1600-6135 |
关键词 | hepatocyte transplantation macrophages T cells survival function |
DOI | 10.1016/j.ajt.2023.07.020 |
通讯作者 | Zhang, Ludi(zhangludi@sibcb.ac.cn) ; Pan, Guoyu(gypan@simm.ac.cn) |
英文摘要 | Hepatocyte transplantation has the potential to treat acute liver failure and correct liver-based metabolic disorders. Proliferating human hepatocytes (ProliHHs) provide a large-scale source as an alternative to primary human hepatocytes. However, host rejection led to inefficient graft survival and function, which hindered the clinical application of cell therapy. Herein, we employed the lentiviral system to overexpress immunomodulatory factors programmed death-ligand 1 (cluster of differentiation 274) (CD274) and cluster of differentiation 47 (CD47) in ProliHHs. CD47+274 overexpression inhibited macrophage and T cell responses in vitro. After transplantation into mice via the spleen without immu-nosuppression, CD47+274 ProliHHs accumulation in the liver significantly increased for 48 hours compared with ProliHHs. Consistent with the in vitro results, CD47+274 ProliHHs were less aggregated and infiltrated by macrophages and also recruited fewer T cells in the liver. Seven days after transplantation, the human albumin level of engineered ProliHHs doubled compared with control group. CD47+274 ProliHHs further ameliorated the liver injury induced using concanavalin A. Overall, our results suggested CD47+274 over expression reduced innate and adaptive immune responses during hepatocyte transplantation, and the survival rate and graft function of transplanted hepatocyte-like cells were all significantly improved. |
WOS关键词 | CELL THERAPY ; TRANSPLANTATION ; REJECTION |
资助项目 | Chinese Academy of Sciences[XDA16020205] ; National Science Foundation of China[82173878] ; Youth Innovation Promotion Association CAS, China ; Independent Deployment Program of the Institute of Pharmaceutical Innovation of the Chinese Academy of Sciences[LX211004] |
WOS研究方向 | Surgery ; Transplantation |
语种 | 英语 |
出版者 | ELSEVIER SCIENCE INC |
WOS记录号 | WOS:001150166300001 |
源URL | [http://119.78.100.183/handle/2S10ELR8/308912] |
专题 | 中国科学院上海药物研究所 |
通讯作者 | Zhang, Ludi; Pan, Guoyu |
作者单位 | 1.Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, CAS Ctr Excellence Mol Cell Sci, State Key Lab Cell Biol, Shanghai, Peoples R China 2.Univ Chinese Acad Sci, CAS Ctr Excellence Mol Cell Sci, Shanghai Inst Biochem & Cell Biol, State Key Lab Cell Biol,Chinese Acad Sci, Shanghai 200031, Peoples R China 3.Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China 4.Shanghai Hexaell Biotech Co Ltd, Shanghai, Peoples R China 5.Nanjing Univ Chinese Med, Sch Chinese Mat Med, Nanjing, Peoples R China 6.Shanghai Tech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China 7.Univ Chinese Acad Sci, Beijing, Peoples R China 8.Univ Chinese Acad Sci, Beijing, Peoples R China 9.Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai, Peoples R China |
推荐引用方式 GB/T 7714 | Ma, Chen,Cao, Huiying,Sun, Zhen,et al. CD47 and PD-L1 overexpression in proliferating human hepatocytes attenuated immune responses and ameliorated acute liver injury in mice[J]. AMERICAN JOURNAL OF TRANSPLANTATION,2023,23(12):1832-1844. |
APA | Ma, Chen.,Cao, Huiying.,Sun, Zhen.,Deng, Qiangqiang.,Liu, Wenjing.,...&Pan, Guoyu.(2023).CD47 and PD-L1 overexpression in proliferating human hepatocytes attenuated immune responses and ameliorated acute liver injury in mice.AMERICAN JOURNAL OF TRANSPLANTATION,23(12),1832-1844. |
MLA | Ma, Chen,et al."CD47 and PD-L1 overexpression in proliferating human hepatocytes attenuated immune responses and ameliorated acute liver injury in mice".AMERICAN JOURNAL OF TRANSPLANTATION 23.12(2023):1832-1844. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。